JNK India Q1FY27: consolidated PAT up sharply YoY to ₹9.6 Cr on 81% revenue growth
PAT +754.05% YoY · revenue +81.48% · margins expanding
₹179.96 Cr
+81.48% YoY
₹9.63 Cr
+754.05% YoY
5.17%
+4.1pp YoY
₹2.05
JNK India's consolidated Q1FY27 revenue came in at ₹179.96 Cr, up 81.5% YoY from ₹99.17 Cr but down 46.8% QoQ from a blowout ₹338.44 Cr in Q4FY26. Consolidated PAT (profit for the period) was ₹9.63 Cr — roughly 8.5x the ₹1.13 Cr posted a year ago, but down 70.9% sequentially from ₹33.04 Cr; basic EPS was ₹2.05 versus ₹0.20 YoY and ₹5.84 QoQ. The YoY jump is the headline, but it is measured off a deliberately weak year-ago base (NPM was just 1.09% then) and is not fully organic: the Process Equipment segment (JNK Chemdist), consolidated only from October 2025, was not present in the year-ago quarter at all, so the auditors themselves flag this quarter as not directly comparable to Q1FY25. Standalone tells a somewhat different, more modest story — standalone revenue grew 65.5% YoY to ₹163.55 Cr (versus 81.5% consolidated) and standalone PAT of ₹13.55 Cr actually exceeds the consolidated PAT of ₹9.63 Cr, because the newly-added Process Equipment subsidiary posted a segment loss and NCI absorbed part of the consolidated profit.
Q1 FY-2027 vs prior quarters
Margins compressed sharply sequentially: consolidated NPM fell to 5.35% from 9.59% in Q4FY26, and operating margin (EBITDA-based) eased to roughly 12.2% from Q4's 13.64% — both a function of Q4 being a seasonally back-loaded execution quarter for this project-driven EPC business, not a structural deterioration. Segment-wise, core Combustion Equipment did the heavy lifting with ₹163.71 Cr revenue and a ₹29.73 Cr segment profit, while Process Equipment added ₹16.25 Cr of revenue but a ₹1.33 Cr segment loss, consistent with a business still ramping post-acquisition.
The stock went into the print at ₹419.2, down 17.5% over the past month of trading.
JNK India provided a positive outlook with an expected revenue growth of 25% to 30% for FY27, supported by a strong order book and operational efficiencies. Management aims to maintain EBITDA margins in the 14%-15% range, reflecting a sustainable and achievable target. The company is strategically expanding its presenc
On guidance, management had targeted 25-30% FY27 revenue growth and a 14-15% EBITDA margin band off a FY26 consolidated revenue base of ₹818.55 Cr; this quarter's ~12.2% operating margin trails that band, and with only one (historically light) quarter in hand against a company whose revenue is heavily back-ended (Q4FY26 alone was nearly double this quarter's print), it is too early to call the full-year guidance met or missed — vsGuidance is marked unknown pending Q2-Q3 execution. No brokerage consensus for this specific quarter's revenue/PAT could be found in a web search, and JNK India has thin analyst coverage (effectively one tracked analyst); vsStreet is marked unknown rather than inferred. No standalone press release/management commentary accompanied this filing — that context is expected from the August 12, 2026 earnings call.
W1
FY27 guidance of 25-30% revenue growth and 14-15% EBITDA margin — Q1 operating margin (~12.2%) trails the band; watch Q2/Q3 for convergence toward guidance
W2
Process Equipment (Chemdist) segment is currently loss-making (₹1.33 Cr segment loss this quarter) — watch for its path to segment breakeven as it ramps post-acquisition
W3
Order-book impact of the TA'ZIZ Salt Project cancellation (July 16, 2026) on FY27 revenue visibility, despite management's stated 'no impact' on already-recognised numbers